11-Assessment of mean platelet volume and soluble CD40 ligand levels in patients with non-dipper hypertension, dippers and normotensives.
Surgit O, Erturk M, Akgul O, Pusuroglu H, Korkmaz AF, Isiksacan N, Gul M, Uzun F, Ozal E, Eksik A.
Clin Exp Hypertens. 2015;37(1):70-4. doi: 10.3109/10641963.2014.897725. Epub 2014 May 27.
PMID: 24866755
12-A comparative analysis of leukocyte and leukocyte subtype counts among isolated systolic hypertensive, systo-diastolic hypertensive, and non-hypertensive patients.
Pusuroglu H, Akgul O, Erturk M, Ozal E, Celik O, Gül M, Surgit O, Oner E, Akturk F, Birant A, Cakmak HA, Uslu N.
Kardiol Pol. 2014;72(8):748-54. doi: 10.5603/KP.a2014.0044. Epub 2014 Feb 14.
PMID: 24526559
13-Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
Belen E, Ozal E, Pusuroglu H.
Heart Vessels. 2016 Sep;31(9):1537-43. doi: 10.1007/s00380-015-0759-9. Epub 2015 Oct 16.
PMID: 26475711
14-Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
Toprak C, Tabakci MM, Simsek Z, Arslantas U, Durmus HI, Ocal L, Demirel M, Ozturkeri B, Ozal E, Kargin R.
Postepy Kardiol Interwencyjnej. 2015;11(4):288-97. doi: 10.5114/pwki.2015.55599. Epub 2015 Jan 12.
PMID: 26677378 Free PMC article.
15-Hematologic and clinical parameters after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis.
Gul M, Uyarel H, Akgul O, Uslu N, Yildirim A, Eksik A, Aksu HU, Ozal E, Pusuroglu H, Erol MK, Bakir I.
16-The relationship between γ-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gul M, Uyarel H, Ergelen M, Ekmekci A, Ozal E, Murat A, Kul S, Celik O, Karaca G, Akturk F, Eksik A.